Literature DB >> 1671015

A case-control study of stillbirths in northeast Brazil.

E M Ferraz1, R H Gray.   

Abstract

An institution based case-control study to determine risk factors for stillbirths was conducted in the city of Natal, NE Brazil, where 90% of deliveries take place in health facilities. Two hundred thirty-four singleton stillborn cases were compared to 2555 liveborn singleton control infants of normal birth-weight and gestational age. Information was obtained by postnatal interview and anthropometry, and review of medical records. Univariate analyses revealed a large number of potential risk factors, but after adjustment by logistic regression only six factors remained significantly associated with stillbirth. These were low maternal weight, less than or equal to 50 kg and a history of pregnancy loss, both with odds ratios (OR) of 1.8, inadequate prenatal care defined as less than five visits (OR = 1.9), gestational complications (OR = 14.2), intrapartum complications (OR = 2.0), and congenital malformations (OR = 8.7). There was also an increased risk of stillbirth among older mothers who smoked (OR = 1.4), and evidence of an interaction between smoking and complications of pregnancy. From the public health perspective, the most important factors amenable to intervention were inadequate prenatal care and antenatal or intrapartum complications which were associated with substantial attributable risks (23.8%, 35.2%, and 10.2%, respectively). Thus, in this population, future reductions of the high stillbirth rate (27.2 per 1000 births) will largely depend on the coverage, utilization, and quality of antenatal and intrapartum care.

Entities:  

Mesh:

Year:  1991        PMID: 1671015     DOI: 10.1016/0020-7292(91)90532-a

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  9 in total

1.  Levels and risk factors for perinatal mortality in Ahmedabad, India.

Authors:  D V Mavalankar; C R Trivedi; R H Gray
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

2.  Assessment of risk factors for stillbirth among pregnant women in Jamaica.

Authors:  Gelen R Del Rosario; Terri Lewis; Beryl Irons; Sheila Campbell-Forrester; Heidi L Weiss; Pauline E Jolly
Journal:  J Obstet Gynaecol       Date:  2004-10       Impact factor: 1.246

3.  Risk factors for stillbirths in a rural community.

Authors:  R Kumar; S Singhi
Journal:  Indian J Pediatr       Date:  1992 Jul-Aug       Impact factor: 1.967

Review 4.  Maternal age and risk of stillbirth: a systematic review.

Authors:  Ling Huang; Reg Sauve; Nicholas Birkett; Dean Fergusson; Carl van Walraven
Journal:  CMAJ       Date:  2008-01-15       Impact factor: 8.262

5.  Predictors of stillbirth among HIV-infected Tanzanian women.

Authors:  Roland Kupka; Tarik Kassaye; Elmar Saathoff; Ellen Hertzmark; Gernard I Msamanga; Wafaie W Fawzi
Journal:  Acta Obstet Gynecol Scand       Date:  2009       Impact factor: 3.636

Review 6.  Preconception care: promoting reproductive planning.

Authors:  Sohni V Dean; Zohra S Lassi; Ayesha M Imam; Zulfiqar A Bhutta
Journal:  Reprod Health       Date:  2014-09-26       Impact factor: 3.223

Review 7.  Preconception care: delivery strategies and packages for care.

Authors:  Zohra S Lassi; Sohni V Dean; Dania Mallick; Zulfiqar A Bhutta
Journal:  Reprod Health       Date:  2014-09-26       Impact factor: 3.223

Review 8.  Maternal smoking and the risk of still birth: systematic review and meta-analysis.

Authors:  Takawira C Marufu; Anand Ahankari; Tim Coleman; Sarah Lewis
Journal:  BMC Public Health       Date:  2015-03-13       Impact factor: 3.295

9.  The BRAzil MAGnesium (BRAMAG) trial: a randomized clinical trial of oral magnesium supplementation in pregnancy for the prevention of preterm birth and perinatal and maternal morbidity.

Authors:  Joao Guilherme B Alves; Carla Adriane Fonseca Leal de Araújo; Isabelle E A Pontes; Angélica C Guimarães; Joel G Ray
Journal:  BMC Pregnancy Childbirth       Date:  2014-07-08       Impact factor: 3.007

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.